Table 2 |
||||||||
|
Expression of PR and p53 in uterine smooth muscle tumors |
||||||||
|
Tumor type |
PR expression |
P53 expression |
||||||
|
|
||||||||
|
High -expression |
Low-expression |
High-expression |
Low-expression |
|||||
|
|
||||||||
|
+3 |
+2 |
+1 |
0 |
+3 |
+2 |
+1 |
0 |
|
|
|
||||||||
|
Non-sarcomatous tumors: |
24/26 |
2/26 |
0/26 |
0/26 |
0/26 |
0/26 |
10/26 |
16/26 |
|
• Leiomyoma |
16/16 |
0/16 |
0/16 |
0/16 |
0/16 |
0/16 |
4/16 |
12/16 |
|
• Atypical leiomyoma |
5/6 |
1/6 |
0/6 |
0/6 |
0/6 |
0/6 |
2/6 |
4/6 |
|
• STUMP* |
3/4 |
1/4 |
0/4 |
0/4 |
0/4 |
0/4 |
4/4 |
0/4 |
|
|
||||||||
|
Leiomyosarcoma |
0/15 |
1/15 |
1/15 |
13/15 |
7/15 |
8/15 |
0/15 |
0/15 |
|
|
||||||||
|
*STUMP = smooth muscle tumor of unknown malignant potential |
||||||||
|
Hewedi et al. Diagnostic Pathology 2012 7:1 doi:10.1186/1746-1596-7-1 |
||||||||
